Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).
AuthorsHargrave, D R
Hann, I I
Hill, Frank G H
Lilleyman, J S
Kinsey, Sally E
Bailey, C C
Chessells, J M
Mitchell, Christopher D
Eden, Tim O B
AffiliationDepartment of Paediatric Oncology, The Royal Marsden Hospital, Sutton, UK. firstname.lastname@example.org
MetadataShow full item record
AbstractIn the last 20 years, the survival rate for children with acute lymphoblastic leukaemia (ALL) has markedly improved, largely owing to a decrease in relapses. However, children still die from complications of treatment and these are potentially preventable. We have analysed data from three large consecutive national protocols for ALL from 1980 to 1997 [Medical Research Council United Kingdom ALL (MRC UKALL) trials VIII, X and XI] to compare the incidence and causes of treatment-related deaths (TRD). The percentage of TRD has fallen from 9% to 2% (UKALL VIII to XI), largely as a result of a decrease in fatal infections. Deaths during induction have fallen from 3% to 1%, the main causes of death being bacterial, followed by fungal infection, while other causes, chiefly haemorrhage, have not declined. Remission deaths also decreased from 6% to 1%, particularly those deaths due to measles and pneumocystis carinii. More guidelines for surveillance and treatment of infections have been included within progressively more intensive protocols. Risk factor analysis showed increased TRD in patients with Down's syndrome, high leucocyte count and older age in UKALL XI. In contrast, the introduction of blocks of intensification was not associated with an increased death rate. While improved supportive care has reduced the incidence of TRD, there is still scope for further reduction by prompt treatment of suspected infection. Maintenance of herd immunity remains of vital importance in avoiding deaths from measles.
CitationProgressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). 2001, 112 (2):293-9 Br. J. Haematol.
JournalBritish Journal of Haematology
- Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
- Authors: Wheeler K, Chessells JM, Bailey CC, Richards SM
- Issue date: 1996 Feb
- Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
- Authors: Chessells JM, Harrison G, Richards SM, Gibson BE, Bailey CC, Hill FG, Hann IM, Medical Research Council Working Party On Childhood Leukaemia.
- Issue date: 2002 Aug
- Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
- Authors: Chessells JM, Harrison G, Richards SM, Bailey CC, Hill FG, Gibson BE, Hann IM
- Issue date: 2001 Oct
- Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
- Authors: Richards S, Burrett J, Hann I, Chessells J, Hill F, Bailey C
- Issue date: 1998 Jul
- Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
- Authors: Chessells JM, Bailey C, Richards SM
- Issue date: 1995 Jan 21